The story of Viagra presents a interesting case for investors in the pharmaceutical sector. While initially a phenomenal success, creating huge profits, the exclusivity lapse and the subsequent flood of generic https://knockoff433008.blogminds.com/the-little-copyright-and-big-pharma-a-risky-play-38643897